Stopping pre-medications before weekly paclitaxel for breast cancer
Part of Cancer, Immune system & allergy, Skin clinical trials.
This study looks at whether stopping routine allergy-prevention medicines before weekly paclitaxel chemotherapy affects your quality of life. If you qualify, you may be assigned to stop or continue these pre-medications and share how you feel.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have breast cancer that has not spread to other parts of the body.
- You are getting a chemotherapy drug called paclitaxel every week for 12 weeks, and it is the only chemotherapy you are receiving.
- You have not had a bad allergic reaction to your first or second dose of paclitaxel.
- You are not taking daily steroid pills for more than 2 weeks.
- You are not pregnant and can answer questionnaires in English or French.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking two natural citrus compounds (hesperidin and diosmin) as daily pills can help prevent or reduce nerve damage (tingling, numbness, or pain in hands/feet) caused by the chemotherapy drug paclitaxel. If it works, it could make treatment more comfortable and improve your quality of life during breast cancer therapy.
This early-phase study tests how epidiferphane works in the body and whether it is safe when combined with standard chemotherapy “taxanes” (paclitaxel or docetaxel) for breast cancer. If you qualify, you may be starting a new taxane treatment plan at the study site, and you would be followed closely for side effects and drug levels.
This study looks at how physical activity and body composition affect the side effects of paclitaxel, a chemotherapy drug, in women with stage II or III breast cancer. It aims to help doctors understand who might have more or fewer side effects during treatment.
This trial tests whether cryotherapy (cooling the hands/feet during chemo) can prevent or lessen nerve pain caused by paclitaxel in people with early breast cancer. It may help you stay more comfortable and function better during treatment.
This trial studies how paclitaxel (a chemotherapy medicine) behaves in the body when given by a specific 1-hour infusion approach. It may help refine dosing for people with cancer using measurements from scans, and it includes a medicine schedule you must match.
This trial tests paclitaxel given as tiny micelle particles for people whose cancer (pancreatic, bile duct, lung, stomach, esophagus, or breast) stopped responding to taxane chemotherapy or did not shrink. The goal is to see if this treatment can help when standard taxanes no longer work.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.